Clinical trial
Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not…
NCT00403000 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00403000 |
|---|---|
| Title | Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy |
| Official title | Phase II Study of Dutasteride in Prostate Cancer Recurrent During Androgen Deprivation Therapy |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | dutasteride |
| Enrollment | 27 |
| Start date | Dec 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Apr 1, 2013 |
| First posted | Nov 23, 2006 |
| Last update posted | May 1, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: